Becton, Dickinson and Company (BDX) announced it received 510(k) clearance from the FDA for the Surgiphor 1000mL for wound irrigation. Surgiphor 1000mL provides a standardized, OR-ready solution that enhances surgical safety and efficacy. Surgiphor 1000mL arrives ready-to-use, eliminating the need for hospital staff to mix solutions by hand.
The company said the expanded Surgiphor portfolio now offers both manual and powered irrigation configurations, giving clinicians flexibility to match the needs of their workflow and patient population.
In pre-market trading on NYSE, BDX shares are down 0.27 percent to $176.00.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.